These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 33070565)

  • 1. Prognostic significance of Bcl-2 expression in primary cutaneous B-cell lymphoma: a reappraisal.
    Pileri A; Agostinelli C; Bertuzzi C; Grandi V; Maio V; Lastrucci I; Santucci M; Pimpinelli N
    Ital J Dermatol Venerol; 2021 Dec; 156(6):642-649. PubMed ID: 33070565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bcl-2, Bcl-6 and CD10 expression in cutaneous B-cell lymphoma: further support for a follicle centre cell origin and differential diagnostic significance.
    Hoefnagel JJ; Vermeer MH; Jansen PM; Fleuren GJ; Meijer CJ; Willemze R
    Br J Dermatol; 2003 Dec; 149(6):1183-91. PubMed ID: 14674895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bcl-2 protein expression is the strongest independent prognostic factor of survival in primary cutaneous large B-cell lymphomas.
    Grange F; Petrella T; Beylot-Barry M; Joly P; D'Incan M; Delaunay M; Machet L; Avril MF; Dalac S; Bernard P; Carlotti A; Esteve E; Vergier B; Dechelotte P; Cassagnau E; Courville P; Saiag P; Laroche L; Bagot M; Wechsler J
    Blood; 2004 May; 103(10):3662-8. PubMed ID: 14726400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. bcl-2 protein expression and correlation with the interchromosomal 14;18 translocation in cutaneous lymphomas and pseudolymphomas.
    Cerroni L; Volkenandt M; Rieger E; Soyer HP; Kerl H
    J Invest Dermatol; 1994 Feb; 102(2):231-5. PubMed ID: 8106752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous b-cell lymphomas of follicular and marginal zone types: use of Bcl-6, CD10, Bcl-2, and CD21 in differential diagnosis and classification.
    de Leval L; Harris NL; Longtine J; Ferry JA; Duncan LM
    Am J Surg Pathol; 2001 Jun; 25(6):732-41. PubMed ID: 11395550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of the t(14;18) chromosomal translocation in primary cutaneous B-cell lymphoma.
    Child FJ; Russell-Jones R; Woolford AJ; Calonje E; Photiou A; Orchard G; Whittaker SJ
    Br J Dermatol; 2001 Apr; 144(4):735-44. PubMed ID: 11298531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early detection of cutaneous lymphoma.
    Abd-el-Baki J; Stefanato CM; Koh HK; Demierre MF; Foss FM
    Oncology (Williston Park); 1998 Oct; 12(10):1521-30; discussion 1532-4. PubMed ID: 9798206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous B-Cell Lymphoma.
    Goyal A; LeBlanc RE; Carter JB
    Hematol Oncol Clin North Am; 2019 Feb; 33(1):149-161. PubMed ID: 30497672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reclassification of 300 primary cutaneous B-Cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers.
    Senff NJ; Hoefnagel JJ; Jansen PM; Vermeer MH; van Baarlen J; Blokx WA; Canninga-van Dijk MR; Geerts ML; Hebeda KM; Kluin PM; Lam KH; Meijer CJ; Willemze R
    J Clin Oncol; 2007 Apr; 25(12):1581-7. PubMed ID: 17353548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of MT2 and anti-bcl-2 protein antibodies in the differentiation of benign from malignant cutaneous infiltrates of B-lymphocytes with germinal center formation.
    Chimenti S; Cerroni L; Zenahlik P; Peris K; Kerl H
    J Cutan Pathol; 1996 Aug; 23(4):319-22. PubMed ID: 8864918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Fas and Fas ligand in cutaneous B-cell lymphomas.
    Zoi-Toli O; Meijer CJ; Oudejans JJ; de Vries E; van Beek P; Willemze R
    J Pathol; 1999 Dec; 189(4):533-8. PubMed ID: 10629554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of STMN1, LMO2, HGAL, AID expression and 1p36 chromosomal abnormalities in primary cutaneous B cell lymphomas.
    Verdanet E; Dereure O; René C; Tempier A; Benammar-Hafidi A; Gallo M; Frouin E; Durand L; Gazagne I; Costes-Martineau V; Cacheux V; Szablewski V
    Histopathology; 2017 Oct; 71(4):648-660. PubMed ID: 28594133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous B-cell lymphomas: 2019 update on diagnosis, risk stratification, and management.
    Wilcox RA
    Am J Hematol; 2018 Nov; 93(11):1427-1430. PubMed ID: 30039522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary cutaneous B-cell lymphomas: recent advances in diagnosis and management.
    Sokol L; Naghashpour M; Glass LF
    Cancer Control; 2012 Jul; 19(3):236-44. PubMed ID: 22710899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and prognostic stratification of cutaneous lymphoma.
    Miyagaki T
    J Dermatol; 2022 Feb; 49(2):210-222. PubMed ID: 34346516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. bcl-2 protein expression in primary cutaneous large B-cell lymphoma is site-related.
    Geelen FA; Vermeer MH; Meijer CJ; Van der Putte SC; Kerkhof E; Kluin PM; Willemze R
    J Clin Oncol; 1998 Jun; 16(6):2080-5. PubMed ID: 9626207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous primary B-cell lymphomas: from diagnosis to treatment.
    Lima M
    An Bras Dermatol; 2015; 90(5):687-706. PubMed ID: 26560215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary cutaneous B-cell lymphoma: a clinical, histological, phenotypic and genotypic study of 21 cases.
    Grønbaek K; Møller PH; Nedergaard T; Thomsen K; Baadsgaard O; Hou-Jensen K; Zeuthen J; Guldberg P; Ralfkiaer E
    Br J Dermatol; 2000 May; 142(5):913-23. PubMed ID: 10809848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoreactivity for bcl-2 protein in cutaneous lymphomas and lymphoid hyperplasias.
    Triscott JA; Ritter JH; Swanson PE; Wick MR
    J Cutan Pathol; 1995 Feb; 22(1):2-10. PubMed ID: 7751474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary cutaneous marginal zone B-cell lymphoma: a recently described entity of low-grade malignant cutaneous B-cell lymphoma.
    Cerroni L; Signoretti S; Höfler G; Annessi G; Pütz B; Lackinger E; Metze D; Giannetti A; Kerl H
    Am J Surg Pathol; 1997 Nov; 21(11):1307-15. PubMed ID: 9351568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.